Psychedelic/Marijuana Research Projects Seeking Volunteers

  • MDMA and Sexual Risk
    http://www.rci.rutgers.edu/~hectorg

    This survey is part of a study being conducted on the effects of MDMA [Ecstasy] on sexual behavior. The study is being conducted by Mr. Hector Garcia of the Graduate School of Applied and Professional Psychology at Rutgers University. Your participation is this survey is completely VOLUNTARY. YOU MAY DECIDE NOT TO PARTICIPATE AT ANY TIME DURING THE SURVEY.

    In order to participate in this study you must be at least 18 years of age, and you must have used MDMA [ECSTASY] at least once in the past month. We will NOT ask for your name, or any information, which would positively identify you such as your social security number, and we will NOT attempt to identify you. Internet Protocol (IP) addresses will automatically be collected with each submission. IP addresses are strings of digits that can be used to identify the computer from which the submission originated, but not the individual who made the submission. IP addresses will be recorded merely to ensure that there is only one response from each address, but they will be purged at the end of the study. Every effort will be made to insure the confidentiality of your responses. However, confidentiality cannot be guaranteed under all foreseeable circumstances, and it is conceivable that confidentiality could be lost. No one will contact you further regarding the study unless you provide contact information along with a written request for contact to the researcher. The results of this study will only be reported collectively, rather than on an individual basis.

    The questions of this survey are of a sexual nature and ask about MDMA [Ecstasy] use. It is possible that some of these questions may be upsetting to you. If that occurs the researchers will not provide counseling, but participants will be referred to the primary investigator's advisor, Dr. James Langenbucher [(732) 445-0908], a licensed psychologist, who will make every reasonable effort to encourage that individual to seek appropriate care. You may choose not to answer any questions that disturb you. If you have any questions about your participation in the study please contact Mr. Garcia at (732) 445-6111 x.906

    Hector Garcia
    Graduate School of Applied and Professional Psychology
    Rutgers University
    Piscataway, NJ 08854

    If you have any questions about your rights as a research subject you many contact Brenda Rutolo, the Sponsored Programs Administrator at Rutgers University at: 732-932-0150, x.2104.

  • Long-term effects of MDMA use
    Cambridge, UK

    Did you take ecstasy/MDMA on a regular basis in the past, but have not for 2 years (for any reason)? Do you live in the UK? Researchers at the University of Cambridge would be extremely grateful if you would be prepared to be in a study in Cambridge, England. Time and travel expenses will be refunded. We hope to add to the current literature on the long-term effects of MDMA. The procedure takes only 2 hours, and the study design addresses many of the problems frequently encountered in MDMA research. If you have taken ecstasy/MDMA on at least 30 separate occasions, the last time being at least 2 years ago, please contact Jon Roiser (jpr24@cam.ac.uk) in complete confidence.

    You do not need to use your real name, and if you wish you may email anonymously from cambridgestudy@hotmail.com (password: cambridge) to Jon Roiser, putting an identifier in the Subject heading. If you use this method, an email will be sent back to the cambridgestudy address within 2 days. An information sheet about the study will be sent to anyone who is interested. Your details will not be kept in electronic or written form following the test without your express permission, and all email contact will be deleted. Please contact Jon Roiser with any more questions about the study or to receive an information sheet. This study is being carried out with approval from the Cambridge Local Research Ethics Committee.

  • Medical marijuana studies for HIV and cancer patients
    San Francisco, California

    Dr. Donald Abrams is looking for patients to participate in two new marijuana studies he is conducting at San Francisco General Hospital. If you have HIV-related painful neuropathy or cancer and are interested in participating in one of these studies, please see http://www.mpp.org/abrams.html

  • MDMA therapy study for treatment of post-traumatic stress disorder (PTSD)
    Charleston, South Carolina

    Volunteers for this study must fit the following criteria:

    1. Women between 18 and 60 years of age with a diagnosis of chronic PTSD according to the guidelines established in the DSM-IV as a result of sexual abuse of any type.
    2. Have a score greater than 15 on the global scale and over 5, 6 and 4 on the subscales of re-experience, avoidance, and arousal increase, respectively, on the PTSD Severity of Symptoms Scale (Echebur a et al., 1997).
    3. At least three months have passed since the sexual abuse took place.
    4. Clinical history and physical examination do not indicate presence of organic illness. The subjects cannot take any drug or medication during the period of the study. 5. The ECG and the general analysis of blood and urine performed on intake must be DPBS/HPM/MDMA/1 60 normal. Minor variation from standard scores are acceptable (+/- 10%).
    6. The body-weight of each subject must be within 15% of the established norms relative to her height, and will fall between 50 and 80 kg.
    7. Accept the procedures of the study and sign the informed consent form.
    8. Have failed at least one previous treatment for resolving the PTSD.

    Exclusion criteria
    1. Subjects with a history of schizophrenic or related disorders (F.2), mood disorders (F.3)
    or personality disorders (F.6) before suffering the sexual abuse. 2. Subjects with a history of drug abuse or abuse of medications according to the criteria specified in the DSM-IV before suffering the sexual abuse.
    3. Subjects who have suffered from any serious organic illness or major surgery in the three months prior to the study.
    4. Subjects with psychiatric disorders (as detailed in #1) in primary family members.
    5. Daily consumption of alcohol greater than 50 g.
    6. Smokers of more than 20 cigarettes per day.
    7. Taking medication regularly in the month previous to the study.
    8. History of allergy or adverse reaction to medication.
    9. History of cardio-vascular, gastro-intestinal, hepatic, or renal pathology or of any other type that suggests an alteration in the absorption, distribution, metabolism or excretion of the medication, or which suggests heightened gastro-intestinal sensitivity to medication.
    10. Subjects unable to understand the nature and consequences of the study or the procedures they are asked to follow.
    11. Subjects who test positive for Hepatitis B, and/or C.
    12. Subjects in fertile years who do not use a reliable birth-control method (oral contraceptives, IUD, tubal ligation).

    If you meet the requirements of this study and you'd like more information, contact the study's investigator, Dr. Michael Mithoefer, at mmit@mindspring.com.

  • Psilocybin study in the treatment of obsessive-compulsive disorder
    Tuscon, Arizona

    Volunteers for this project must fit the following criteria:
    Ten subjects (ideally 5 males and 5 females) between the ages of 21-60 with moderate to severe and refractory OCD (DSM-IV), but no concurrent medical or psychiatric (AXIS-I) disorders, and no past personal or family history of psychosis will be enrolled. Subjects must have failed at least one adequate trial of usual care treatment. They must have had prior experience with psychedelic drugs including at least one but no more than twenty experiences with any of the following: (LSD, psilocybin, mescaline or other related compounds. The use of these substances should have occurred as far as ten years back, and not closer than one month prior to enrollment. Non-related compounds like MDMA and marijuana do not qualify as previous experience).

    Criteria for exclusion of potential subjects:
    Subjects will be admitted if after diagnostic interview using the Structured Clinical Interview for DSM-IV (SCID) they are found to have no comorbid mental disorder, substance abuse problem, or a personal or family history of psychosis. Healthy subjects must also be free of any medical illness based on physical examination and routine blood testing. They should not require any prescription or over the counter medications on a regular basis, and any medication they may have taken, should have been stopped long enough in the past to allow for their elimination prior to start the administration of the study drug. Women who are pregnant, lactating, or unwilling/unable to practice medically acceptable birth control during the study, will also be excluded.

    If you meet the requirements of this study and you'd like more information, contact the study's investigator, Dr. Francisco Moreno, at fmoreno@u.arizona.edu.